What is FEED (FEED) stock price today?

FEED (FEED) is currently trading at $1.03, up 0% today.

What is FEED P/E ratio?

FEED's P/E ratio is -0.02. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is FEED return on equity (ROE)?

FEED's return on equity (ROE) is -60.47%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is FEED's market cap?

FEED has a market capitalization of $797964.

NCM · Medical - Specialties

FEED (FEED) Stock

$1.03 +0.00% NCM: FEED Healthcare

Valuation

Metric	Value
Price	$1.03
Market Cap	$797964
P/E Ratio	-0.02
P/B Ratio	0.06
P/S Ratio	1.54
EPS (TTM)	$-19.54
52-Week High	$5.98
52-Week Low	$0.29
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-60.47%
ROA	-54.61%
ROCE	-48.53%
Gross Margin	-366.67%
Operating Margin	-400.00%
Net Margin	-7.44%
Debt/Equity	0.04
Current Ratio	1.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.0M	$1.0M	$2.0M	$3.0M	$3.0M
Operating Profit	$-6.0M	$-5.0M	$-3.0M	$-4.0M	$-12.0M
Net Profit	$-14.0M	$-5.0M	$-4.0M	$-4.0M	$-18.0M
EPS	$-14984.16	$-5065.68	$-2799.00	$-1647.60	$-234.48
Op Margin	-335.3%	-666.5%	-150.5%	-140.0%	-459.7%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$9.0M	$6.0M	$7.0M	$4.0M	$41.0M
Total Liabilities	$2.0M	$3.0M	$3.0M	$3.0M	$8.0M
Cash	$8.0M	$3.0M	$3.0M	$1.0M	$4.0M
Borrowings	$0	$0	$0	$0	$1.0M

Latest News

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform GlobeNewswire · Jul 15, 2026 ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool GlobeNewswire · Jul 9, 2026 ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation GlobeNewswire · Jun 9, 2026 ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network GlobeNewswire · Jun 5, 2026 ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System GlobeNewswire · Jun 3, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-4.0M	$-7.0M	$-4.0M	$-3.0M	$-9.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$-5.0M	$1.0M	$-3.0M	$4.0M
Free Cash Flow	$-4.0M	$-7.0M	$-4.0M	$-3.0M	$-9.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.22
FCF Yield	-395.80%
Quick Ratio	0.31
Interest Coverage	-61.10
Return 1Y	-95.53%
Return 3Y	-99.89%
Return 5Y	-99.97%

Ownership

Insiders Held1.48%

Institutions Held1.04%

Institutions Float Held1.06%

Institutional Holder	Shares	Report Date
Geode Capital Management, LLC	22,417	2026-03-31
Schonfeld Strategic Advisors Llc	13,545	2026-03-31
International Assets Investment Management, LLC	10,000	2026-03-31
Osaic Holdings Inc.	10,000	2026-03-31
Morgan Stanley	10,000	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$336.64	-1.11%	38.93	$4.94T	0.32%
MSFTMicrosoft Corporation	$535.07	+2.38%	28.68	$3.97T	0.76%
GOOGLAlphabet Inc.	$351.66	+0.97%	16.94	$4.26T	0.26%
AMZNAmazon.com, Inc.	$262.43	+3.29%	19.82	$2.82T	0.00%
METAMeta Platforms, Inc.	$718.67	-0.31%	27.93	$1.83T	0.28%

About FEED

FEED is led by CEO Doron Robert Besser, employs 31 people, headquartered in US, publicly traded since 2025.

FEED stock trades at $1.03 with a market capitalization of $797964. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of 0.06, price-to-sales of 1.54. Over the past 52 weeks the stock has ranged between $0.29 and $5.98, and currently trades 82.8% below its 52-week high.

On profitability, FEED generates a return on equity (ROE) of -60.47%, return on capital employed of -48.53%, an operating margin of -400.00%, a net profit margin of -7.44%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides